Edition:
United Kingdom

Kaken Pharmaceutical Co Ltd (4521.T)

4521.T on Tokyo Stock Exchange

4,995JPY
23 Aug 2019
Change (% chg)

¥5 (+0.10%)
Prev Close
¥4,990
Open
¥5,000
Day's High
¥5,020
Day's Low
¥4,970
Volume
91,200
Avg. Vol
115,660
52-wk High
¥6,120
52-wk Low
¥4,535

Latest Key Developments (Source: Significant Developments)

Kaken Pharmaceutical says distribution agreement for Clenafin in Hong Kong and Macau
Tuesday, 2 Oct 2018 

Oct 2(Reuters) - Kaken Pharmaceutical Co Ltd <4521.T>:Says Kaken Pharmaceutical Co Ltd (Kaken) and Main Life Corp., Ltd. (Main Life) announced today that Kaken and Main Life concluded an exclusive distribution agreement for the topical formulation for Onychomycosis “Clenafin/Jublia” in Hong Kong and Macau.  Full Article

Kaken Pharmaceutical signs exclusive distribution agreement for Clenafin/Jublia in Taiwan
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Kaken Pharmaceutical Co Ltd <4521.T>:Says co signed an exclusive distribution agreement with Tai Tien Pharmaceuticals Co Ltd (Tai Tien), which is a subsidiary of Mitsubishi Tanabe Pharma Corporation <<<4508.T>>>, for the topical formulation for Onychomycosis "Clenafin/Jublia" (product) in Taiwan.According to the agreement, co grants to Tai Tien the exclusive right for sales of the product in Taiwan and Tai Tien expects to launch the product in 2018.  Full Article